Results
10,868 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 43 | Baller LanceDirector, 10% Owner |  GBCSSELECTIS HEALTH, INC.Open-market purchase | BUY | $14K 6,192 sh | Jan 14, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 43 | Baller LanceDirector, 10% Owner | GBCSSELECTIS HEALTH, INC. Open-market purchase | BUY | $14K 6,192 sh | Jan 14, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $1.45M 90.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $1.37M 49.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 40 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner |  MNTRMentor Capital, Inc.Open-market purchase | BUY | $204K 11 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector |  PSMTPRICESMART INCOpen-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $205K 1,499 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 176 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $452K 1,527 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | Allison EricChief Product Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLOClough Global Opportunities FundOpen-market purchase | BUY | $1,274 213 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLVClough Global Dividend & Income FundOpen-market purchase | BUY | $774 124 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $34K 200.0K sh | Jan 14, 2026 traded Jan 8, 2026 |
| 37 | Baker Bruce DDirector |  CMTVCOMMUNITY BANCORP /VTOpen-market purchase | BUY | $5,040 180 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $7,047 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $467K 5,182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $17K 47 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $34K 92 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Snow Colton MatthewSVP, Chief Commercial Officer | SNCYSun Country Airlines Holdings, Inc. Open-market sale | SELL | $13K 759 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Bevirt JoeBenDirector, CEO and Chief Architect, 10% Owner | JOBYJoby Aviation, Inc. Open-market sale | SELL | $24K 1,630 sh | Jan 14, 2026 traded Jan 13, 2026 |